Levels of ADAM10 are reduced in Alzheimer’s disease CSF

被引：0
作者：
Aitana Sogorb-Esteve
María-Salud García-Ayllón
Johan Gobom
Jordi Alom
Henrik Zetterberg
Kaj Blennow
Javier Sáez-Valero
机构：
[1] Universidad Miguel Hernández-CSIC,Instituto de Neurociencias de Alicante
[2] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED),Servicio de Neurología, Hospital General Universitario de Elche
[3] Unidad de Investigación,Clinical Neurochemistry Laboratory
[4] Hospital General Universitario de Elche,Department of Neuroscience and Physiology
[5] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),Department of Molecular Neuroscience
[6] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),undefined
[7] Sahlgrenska University Hospital,undefined
[8] the Sahlgrenska Academy at the University of Gothenburg,undefined
[9] UCL Institute of Neurology,undefined
[10] UK Dementia Research Institute at UCL,undefined
来源：
Journal of Neuroinflammation | / 15卷
关键词：
Prodomain; Amyloid Precursor Protein (APP); ADAM10 Levels; ADAM10 Antibody; Ectodomain Antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies [J].
Anitha, K. ;
Singh, Mandeep Kumar ;
Kohat, Komal ;
Varshini, Sri T. ;
Chenchula, Santenna ;
Padmavathi, R. ;
Amerneni, Lakshmi Sahitya ;
Vardhan, Vishnu K. ;
Bai, Mythili K. ;
Chavan, Madhav Rao ;
Bhatt, Shvetank .
MOLECULAR NEUROBIOLOGY, 2025, 62 (02) :2314-2332
[32]   Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin [J].
Niikura, T ;
Tajima, H ;
Kita, Y .
CURRENT NEUROPHARMACOLOGY, 2006, 4 (02) :139-147
[33]   Metal Metabolic Homeostasis Disruption and Early Initiation of Mechanism for Alzheimer's Disease [J].
Zhao Bao-Lu ;
Wan Li .
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2012, 39 (08) :756-763
[34]   Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer's Disease [J].
Eysert, Fanny ;
Kinoshita, Paula Fernanda ;
Mary, Arnaud ;
Vaillant-Beuchot, Loan ;
Checler, Frederic ;
Chami, Mounia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) :1-29
[35]   Reduction of AHI1 in the serum of Taiwanese with probable Alzheimer's disease [J].
Sheu, Jau-Jiuan ;
Yang, Li-Yu ;
Sanotra, Monika Renuka ;
Wang, Sen-Te ;
Lu, Hsien-Tsung ;
Kam, Rachel Sook Yee ;
Hsu, I-Uen ;
Kao, Shu-Huei ;
Lee, Ching-Kuo ;
Shieh, Jonathan Chang-Cheng ;
Lin, Yung-Feng .
CLINICAL BIOCHEMISTRY, 2020, 76 :24-30
[36]   The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease [J].
Shah, Hirak ;
Patel, Ashish ;
Parikh, Vruti ;
Nagani, Afzal ;
Bhimani, Bhargav ;
Shah, Umang ;
Bambharoliya, Tushar .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020, 19 (03) :184-194
[37]   A Novel Cell-based β-secretase Enzymatic Assay for Alzheimer's Disease [J].
Herculano, Bruno De Araujo ;
Wang, Zhe ;
Song, Weihong .
CURRENT ALZHEIMER RESEARCH, 2019, 16 (02) :128-134
[38]   Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease [J].
Gandy, S .
NEUROBIOLOGY OF AGING, 2002, 23 (06) :1009-1016
[39]   Glycosaminoglycan-induced activation of the β-secretase (BACE1) of Alzheimer's disease [J].
Klaver, David W. ;
Wilce, Matthew C. J. ;
Gasperini, Robert ;
Freeman, Craig ;
Juliano, John Paul ;
Parish, Christopher ;
Foa, Lisa ;
Aguilar, Marie-Isabel ;
Small, David H. .
JOURNAL OF NEUROCHEMISTRY, 2010, 112 (06) :1552-1561
[40]   Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease [J].
Ryan, Natalie S. ;
Biessels, Geert-Jan ;
Kim, Lois ;
Nicholas, Jennifer M. ;
Barber, Philip A. ;
Walsh, Phoebe ;
Gami, Priya ;
Morris, Huw R. ;
Bastos-Leite, Antonio J. ;
Schott, Jonathan M. ;
Beck, Jon ;
Mead, Simon ;
Chavez-Gutierrez, Lucia ;
de Strooper, Bart ;
Rossor, Martin N. ;
Revesz, Tamas ;
Lashley, Tammaryn ;
Fox, Nick C. .
NEUROBIOLOGY OF AGING, 2015, 36 (12) :3140-3151
12345